Galapagos | Ativos



Assets Alterar Data
argenx SE 7.18B 973.07M 2025-06
AstraZeneca USD 112.42B 6.17B 2025-06
Biogen USD 28.33B 297.1M 2025-06
Genmab DKK 6.46B 122M 2025-06
Gilead Sciences USD 55.72B 713M 2025-06
GlaxoSmithKline GBP 59.26B 1.45B 2025-06
GRIFOLS EUR 19.77B 1.21B 2025-06
Hikma Pharmaceutical USD 5.13B 286M 2024-12
Incyte USD 5.82B 71.99M 2025-06
Merck EUR 47.35B 2.02B 2025-06
Neurocrine Biosciences USD 3.89B 202.1M 2025-06
Novartis USD 104.4B 4.45B 2025-06
Roche Holding CHF 101.8B 6.02B 2024-12
Sanofi 124.96B 6.93B 2025-06
UCB EUR 17.35B 1.72B 2024-12
Vertex Pharmaceuticals USD 24.04B 1.16B 2025-06


Galapagos Ativos - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.